Is performing lobectomy after the use of bevacizumab for a lung tumor dangerous?
Ann Med Surg (Lond)
; 6: 46-9, 2016 Mar.
Article
em En
| MEDLINE
| ID: mdl-27158486
ABSTRACT
Recent new drugs, such as bevacizumab (Bev), also result in a remarkable response. However, the safety of major lung resection after the use of Bev remains controversial. Is it really dangerous to perform major lung resection after the use of Bev for a lung tumor? In this report, we describe two patients who underwent surgery safely without fragile pathological findings of the vessels.
Bev, bevacizumab; Bevacizumab; CBDCA, carboplatin; CDDP, cisplatin; CT, computed tomography; DTX, docetaxel; FDG, fluorodeoxyglucose; LA-NSCLC NSCLC, locally advanced non-small cell carcinoma; Lung cancer; PET, positron emission tomography; PTX, paclitaxel; Surgery; VEGF, vascular endothelial growth factor
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article